Merck's new formulation could help secure a larger share of Keytruda's sales after the cancer drug's U.S. patent expires in ...

The FDA's digital health advisory committee is expected to weigh in on how generative AI should be regulated by the agency.

Robert F. Kennedy Jr.'s nonprofit, Children’s Health Defense, is involved in vaccine lawsuits against agencies he could wind ...

The FDA’s decision to allow the compounding of GLP-1 weight loss drugs could undermine its public health obligations, writes ...

At AHA, Phase 2 results from Eli Lilly and Silence Therapeutics are seen as signs of a "major new path" of cardiovascular ...

The H5N1 virus that infected a Canadian teen appears not to have spread, but it shows signs of mutation that makes flu ...

This is the online version of STAT's email newsletter Health Care Inc, delivered to your inbox every Monday. Sign up here. ...

Robert F. Kennedy Jr. would have broad power as HHS secretary to strip vaccine makers' protections against lawsuits ...

In today's biotech news, Zepbound trial data, Regenxbio's Duchenne muscular dystrophy treatment, and Intellia's promising ...

The overture to the American Heart Association’s conference, coming as the organization celebrates its 100th year, began with Valentin Fuster of Mount Sinai Hospital lamenting the predicted shift in ...

Leaders throughout the biopharma world and scientific community struggled to process news on Thursday that President-elect Donald Trump has tapped Robert F. Kennedy Jr. to lead the Department of ...

Cancer cases are on the rise among people under 50 — and researchers aren’t sure why. A recent study by the American Cancer ...